Cutler Group LP Aurinia Pharmaceuticals Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$7.13 - $9.49 $26,687 - $35,521	3,743 Added 436.76%	4,600 $41,000
Q3 2023 Nov 07, 2023	SELL	$7.77 - $12.27 $10,069 - $15,901	-1,296 Reduced 60.2%	857 $6,000
Q2 2023 Jul 18, 2023	SELL	$8.96 - $11.69 $7,114 - $9,281	-794 Reduced 26.94%	2,153 $20,000
Q1 2023 May 01, 2023	SELL	$5.94 - $11.27 $7,193 - $13,647	-1,211 Reduced 29.12%	2,947 $32,000
Q4 2022 Feb 07, 2023	BUY	$4.11 - $8.14 $3,699 - $7,326	900 Added 27.62%	4,158 $17,000
Q3 2022 Oct 25, 2022	SELL	$6.66 - $12.39 $137,076 - $255,010	-20,582 Reduced 86.33%	3,258 $24,000
Q2 2022 Aug 04, 2022	SELL	$8.95 - $12.8 $31,978 - $45,734	-3,573 Reduced 13.03%	23,840 $239,000
Q1 2022 Apr 14, 2022	SELL	$10.05 - $22.48 $460,078 - $1.03 Million	-45,779 Reduced 62.55%	27,413 $339,000
Q4 2021 Jan 18, 2022	BUY	$17.78 - $33.08 $454,439 - $845,491	25,559 Added 53.66%	73,192 $1.67 Million
Q3 2021 Oct 26, 2021	BUY	$10.93 - $23.55 $420,072 - $905,097	38,433 Added 417.75%	47,633 $1.05 Million
Q2 2021 Jul 19, 2021	BUY	$10.0 - $14.52 $85,000 - $123,420	8,500 Added 1214.29%	9,200 $119,000
Q1 2021 Apr 26, 2021	SELL	$12.3 - $18.73 $56,580 - $86,158	-4,600 Reduced 86.79%	700 $9,000
Q4 2020 Jan 21, 2021	BUY	$12.94 - $16.05 $31,056 - $38,520	2,400 Added 82.76%	5,300 $73,000
Q3 2020 Oct 27, 2020	BUY	$13.19 - $16.66 $5,276 - $6,664	400 Added 16.0%	2,900 $42,000
Q2 2020 Jul 22, 2020	SELL	$14.12 - $18.33 $4,236 - $5,498	-300 Reduced 10.71%	2,500 $40,000
Q3 2019 Oct 28, 2019	SELL	$5.34 - $6.59 $14,418 - $17,793	-2,700 Reduced 49.09%	2,800 $14,000
Q2 2019 Aug 09, 2019	BUY	$6.05 - $6.75 $8,470 - $9,450	1,400 Added 34.15%	5,500 $36,000
Q1 2019 May 10, 2019	SELL	$6.06 - $7.64 $3,030 - $3,820	-500 Reduced 10.87%	4,100 $26,000
Q4 2018 Feb 05, 2019	BUY	$5.08 - $6.83 $20,320 - $27,320	4,000 Added 666.67%	4,600 $31,000
Q1 2018 May 11, 2018	SELL	$4.85 - $5.99 $9,215 - $11,381	-1,900 Reduced 76.0%	600 $3,000
Q4 2017 Jan 17, 2018	SELL	$4.53 - $7.09 $12,684 - $19,852	-2,800 Reduced 52.83%	2,500 $11,000
Q3 2017 Oct 17, 2017	BUY	$5.71 - $6.9 $30,263 - $36,570	5,300	5,300 $33,000

Others Institutions Holding AUPH

# of Institutions

223

Shares Held

59.4M

Call Options Held

1.17M

Put Options Held

1.54M

Black Rock Inc. New York, NY

9.27M
Shares

$73.9 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

8.2M
Shares

$65.4 Million
1.0% of portfolio
Tang Capital Management LLC San Diego, CA

7.23M
Shares

$57.6 Million
4.52% of portfolio
Nea Management Company, LLC Timonium, MD

3.97M
Shares

$31.6 Million
2.22% of portfolio
State Street Corp Boston, MA

2.95M
Shares

$23.5 Million
0.0% of portfolio

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.13B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account